AC005392.2 knockdown markedly restrained SOX2-mediated glycolysis and VM formation, whereas AC005392.2 overexpression rescued the inhibition of glycolysis and VM formation caused by SOX2 depletion, supporting the involvement of AC005392.2 in SOX2-driven malignant CRC phenotypes. Here, SOX2 is linked to colorectal carcinoma.